三级aa视频在线观看-三级国产-三级国产精品一区二区-三级国产三级在线-三级国产在线

  Home>News Center>Life
         
 

Cheap AIDS pill as good as pricey brands
(Agencies)
Updated: 2004-07-03 10:21

A cheap three-in-one generic AIDS pill from India is just as good as more expensive branded medicines and should be widely used in developing countries, researchers said on Friday.

Lack of scientific evidence about the clinical effectiveness of such generic fixed-dose combinations has until now caused some international AIDS donors to refuse to fund their use.

But a team from the French national agency for AIDS research and Swiss charity Medecins sans Frontieres said Cipla's Triomune performed as well as brand drugs in the first open clinical study in a developing country.

They found that 80 percent of HIV-infected patients given the tablet twice a day had undetectable levels of virus in their blood after six months treatment.

Results of the study involving 60 patients in Cameroon, 92 percent of whom had full-blown AIDS, were published in The Lancet medical journal.

“This generic fixed-dose combination (FDC) gives results comparable to those seen in the developed world using triple-drug therapy comprising brand name drugs,” said study co-ordinator Eric Delaporte.

“It is now no longer possible to raise scientific uncertainty as an objection to the widespread utilization of FDCs in the developing countries.”

In addition to being cheaper, drugs like Triomune -- which contains GlaxoSmithKline's lamivudine, Bristol-Myers Squibb's stavudine and Boehringer Ingelheim's nevirapine -- are simpler to use since patients need to take only two pills a day.

As such, they have a major role to play in meeting the World Health Organization's goal of getting antiretrovirals to three million people in the developing world by the end of 2005, N. Kumarasamy of the YRG Centre for AIDS Research and Education in Madras wrote in a commentary accompanying the research.

Controversy remains

The WHO has judged Triomune and another Indian combination called Triviro, from Ranbaxy Laboratories, to be safe and effective under a scheme that “prequalifies” them for use.

But both products -- which use compounds still covered by patents -- remain controversial.

Washington has barred groups receiving U.S. government funds from buying them, insisting only drugs approved by the Food and Drug Administration be used.

U.S. officials and Western pharmaceutical executives argue health providers are taking a risk by using medicines which have not passed the rigorous standards of the U.S. drugs watchdog.

Worries about the quality of Indian medicines were fuelled last month when the WHO removed two Cipla products -- though not Triomune -- from its prequalification list because they had not been proven to be equivalent to the original products.

Cipla says it is collecting data from new studies which should lead to the drugs being re-instated.

In Cameroon, where drugs are subsidized by the government, the cost of one month’s Triomune is $20, compared to $35 for the equivalent brand name therapy, even after heavy discounting by big pharmaceutical companies.

Elsewhere, cost differences can vary by as much as 100 percent, according to Medecins sans Frontieres.



Jackie Chan's new film 'The Myth'
CK over the top
Stephen Chow's kong fu to hit Mainland cinemas
  Today's Top News     Top Life News
 

Stress kills workaholic academics at young age

 

   
 

Efforts urged to curb floods, drought

 

   
 

China opposes foreign interference in HK

 

   
 

Ministry battles telecom price wars

 

   
 

UK indicts three in shell-fish drownings

 

   
 

Migrant workers given classes on AIDS

 

   
  Marlon Brando dies in Los Angeles hospital
   
  Apple plans new iMac, but delays shipment until Sept
   
  Fragrance makers hook up with Hollywood stars
   
  Piano maker tunes into China's growing middle class
   
  Nation hurries to salvage undersea cultural relics
   
  Panda smokes draw a crowd
   
 
  Go to Another Section  
 
 
  Story Tools  
   
  Feature  
  Oops! Britney to do marriage again  
Advertisement
         
主站蜘蛛池模板: 在线观看网 | 麻豆国产果冻传媒网站入口 | 亚洲国产品综合人成综合网站 | 大胆国模一区二区三区伊人 | 麻豆视频在线免费观看 | 欧美日韩国产精品自在自线 | 邪恶亚洲 | 国产成a人片在线观看视频99 | 欧美亚洲综合另类在线观看 | 成年人黄色在线观看 | 在线观看日本一区二区 | 特级毛片全部免费播放a一级 | 精品免费久久久久国产一区 | 视频办公室添的我好爽 | 色免费视频 | 国产片性视频免费播放 | 国产黄色片在线观看 | 色天天天综合色天天碰 | a级一级黄色片 | 久久国产香蕉一区精品 | 国产片一级aaa毛片视频 | 可以免费观看的一级毛片 | 成人亚洲欧美综合 | 国产一级黄色影片 | 自偷自拍亚洲欧美清纯唯美 | 国产精品乳摇在线播放 | 中国免费黄色片 | 香蕉在线观看999 | 99久久综合九九亚洲 | 57pao一国产成永久免费 | 黄色网页在线免费观看 | 国产高清美女一级a毛片久久w | 亚洲国产伦理 | 成人视屏网站 | 亚洲a在线观看 | 99久久伊人一区二区yy5099 | 国产高清在线精品一区在线 | 国产第一页久久亚洲欧美国产 | 亚洲视频 在线观看 | 高清中文字幕视频在线播 | 91麻豆精品国产综合久久久 |